Table .
Publication | Number of patients | StudyOrigin | Pleural thickening and/or effusion | Air bubble sign | Nodules | Reversedhalo sign | Spiderweb sign | LAP | Pericardial effusion |
---|---|---|---|---|---|---|---|---|---|
Chung et al. [11] | 21 | China | 0 (0%) | - | 0 (0%) | - | - | 0 (0%) | - |
Bernheim et al. [13] | 121 | U.S.A. | 1 (0.8%) | - | 0 (0%) | 2 (1.7%) | - | 0 (0%) | - |
Wu et al. [14] | 80 | China | 5 (6%) | - | - | - | 20 (25%) | 3 (4%) | 4 (5%) |
Song et al. [18] | 51 | China | 4 (8%) | - | - | - | - | 3 (6%) | 3 (6%) |
Pan et al. [19] | 63 | China | - | - | 8 (12.7%) | - | - | - | - |
Ng et al. [20] | 21 | China | 0 (0%) | - | 1 (4.8%) | 2 (9.6%) | - | 0 (0%) | 0 (0%) |
Pan et al. [21] | 21 | China | - | - | - | - | - | 0 (0%) | - |
Han et al. [22] | 108 | China | 0 (0%) | - | - | - | - | 0 (0%) | 0 (0%) |
Xu et al. [23] | 90 | China | 4 (4%) | - | - | - | - | 1 (1%) | 1 (1%) |
Zhao et al. [24] | 101 | China | 14 (13.9%) | - | 23 (22.8%) | - | - | 1 (1%) | - |
Zhou et al. [25] | 62 | China | 6 (9.7%) | 34 (54.8%) | - | - | - | 0 (0%) | - |
Xu et al. [26] | 41 | China | 2 (7.1%) | - | - | - | - | 1(3.6%) | - |
Li et al. [27] | 51 | China | 1 (2.0 %) | - | 11 (21.6%) | 2 (3.9 %) | - | 0 (0%) | - |
Yang et al. [28] | 149 | China | 10 (6.7%) | 12 (8.1%) | 3 (2%) | - | - | 7 (4.7%) | - |
Ai et al. [29] | 888 | China | - | - | 24 (3%) | - | - | - | - |
Li et al. [30] | 83 | China | 7 (8.4%) | - | 6 (7.2%) | - | 21 (25.3%) | 7 (8.4%) | 4 (4.8%) |
Xiong et al. [31] | 42 | China | 5 (12%) | - | - | - | - | 12 (29%) | 0 (0%) |
Bai et al. [32] | 219 | China | 32 (15%) | - | 70 (32%) | 11 (5%) | - | 6 (3%) | - |
Cheng et al. [33] | 11 | China | 0 (0%) | 1 (9.1) | 3 (27.3) | - | - | 0 (0%) | - |
Shi et al. [34] | 81 | China | 4 (5%) | 8 (10%) | 5 (6%) | - | - | 5 (6%) | - |
Wang et al. [35] | 93 | China | 8 (8.6%) | 12 (12.9%) | 17 (18.3%) | 14 (15.1%) | - | 6 (6.5%) | - |
Fan et al. [36] | 150 | China | 6 (4%) | - | 18 (12%) | - | - | 2 (1.3%) | - |
Colombi et al. [37] | 236 | Italy | 47 (20%) | - | - | - | - | 57 (24%) | - |
Zhang et al. [38] | 120 | China | 9 (8%) | - | 65 (54%) | - | - | 5 (4%) | - |
Zhu et al. [39] | 72 | China | 3 (6.8) | 36 (50%) | - | - | - | - | - |
Wang et al. [40] | 110 | China | 1 (0.9%) | - | - | - | - | - | - |
Li et al. [41] | 56 | China | 5 (8.9%) | - | 0 (0%) | - | - | 0 (0%) | - |
Guan et al. [42] | 47 | China | 0 (0%) | - | 1 (2.1%) | - | - | 0 (0%) | - |
Liu et al. [43] | 67 | China | 3 (4.5%) | - | - | - | - | - | - |
LAP; lymphadenopathy.